Determinants and risk factors of gastroenteritis in the general population, a web-based cohort between 2014 and 2017 in France.


Journal

BMC public health
ISSN: 1471-2458
Titre abrégé: BMC Public Health
Pays: England
ID NLM: 100968562

Informations de publication

Date de publication:
21 Jul 2020
Historique:
received: 26 02 2020
accepted: 05 07 2020
entrez: 23 7 2020
pubmed: 23 7 2020
medline: 15 12 2020
Statut: epublish

Résumé

Although it is rarely fatal in developed countries, acute gastroenteritis (AGE) still induces significant morbidity and economic costs. The objective of this study was to identify factors associated with AGE in winter in the general population. A prospective study was performed during winter seasons from 2014 to 2015 to 2016-2017. Participants filled an inclusion survey and reported weekly data on acute symptoms. Factors associated with having at least one AGE episode per winter season were analyzed using the generalized estimating equations (GEE) approach. They were 13,974 participants included in the study over the three seasons. On average, 8.1% of participants declared at least one AGE episode during a winter season. People over 60 declared fewer AGE episodes (adjusted OR (aOR) = 0.76, 95% CI [0.64; 0.89]) compared to individuals between 15 and 60 years old, as well as children between 10 and 15 (aOR = 0.60 [0.37; 0.98]). Overweight (aOR = 1.25 [1.07; 1.45]) and obese (aOR = 1.47 [1.19; 1.81]) individuals, those having frequent cold (aOR = 1.63 [1.37; 1.94]) and those with at least one chronic condition (aOR = 1.35 [1.16; 1.58]) had more AGE episodes. Living alone was associated with a higher AGE episode rate (aOR = 1.31 [1.09; 1.59]), as well as having pets at home (aOR = 1.23 [1.08; 1.41]). Having a better knowledge of AGE determinants will be useful to adapt public health prevention messages.

Sections du résumé

BACKGROUND BACKGROUND
Although it is rarely fatal in developed countries, acute gastroenteritis (AGE) still induces significant morbidity and economic costs. The objective of this study was to identify factors associated with AGE in winter in the general population.
METHODS METHODS
A prospective study was performed during winter seasons from 2014 to 2015 to 2016-2017. Participants filled an inclusion survey and reported weekly data on acute symptoms. Factors associated with having at least one AGE episode per winter season were analyzed using the generalized estimating equations (GEE) approach.
RESULTS RESULTS
They were 13,974 participants included in the study over the three seasons. On average, 8.1% of participants declared at least one AGE episode during a winter season. People over 60 declared fewer AGE episodes (adjusted OR (aOR) = 0.76, 95% CI [0.64; 0.89]) compared to individuals between 15 and 60 years old, as well as children between 10 and 15 (aOR = 0.60 [0.37; 0.98]). Overweight (aOR = 1.25 [1.07; 1.45]) and obese (aOR = 1.47 [1.19; 1.81]) individuals, those having frequent cold (aOR = 1.63 [1.37; 1.94]) and those with at least one chronic condition (aOR = 1.35 [1.16; 1.58]) had more AGE episodes. Living alone was associated with a higher AGE episode rate (aOR = 1.31 [1.09; 1.59]), as well as having pets at home (aOR = 1.23 [1.08; 1.41]).
CONCLUSIONS CONCLUSIONS
Having a better knowledge of AGE determinants will be useful to adapt public health prevention messages.

Identifiants

pubmed: 32693787
doi: 10.1186/s12889-020-09212-4
pii: 10.1186/s12889-020-09212-4
pmc: PMC7372820
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1146

Références

Am J Public Health. 1991 Jan;81(1):97-9
pubmed: 1983924
Gastroenterol Clin North Am. 2001 Sep;30(3):625-35
pubmed: 11586549
Epidemiol Infect. 2008 Jul;136(7):886-94
pubmed: 17686196
N Engl J Med. 2014 Apr 17;370(16):1532-40
pubmed: 24738670
Clin J Am Soc Nephrol. 2008 Sep;3(5):1487-93
pubmed: 18650409
Epidemiol Infect. 2003 Aug;131(1):591-7
pubmed: 12948356
Epidemiol Infect. 2006 Feb;134(1):111-8
pubmed: 16409657
Int J Infect Dis. 2012 Oct;16(10):e714-23
pubmed: 22784546
Epidemiol Infect. 2008 Apr;136(4):451-60
pubmed: 17565767
Am J Epidemiol. 2001 Oct 1;154(7):666-74
pubmed: 11581101
PLoS One. 2013 Sep 11;8(9):e73675
pubmed: 24040020
Epidemiol Infect. 2016 Oct;144(13):2831-9
pubmed: 26964750
Curr Opin Infect Dis. 2002 Aug;15(4):355-67
pubmed: 12130931
Epidemiol Infect. 2004 Aug;132(4):607-17
pubmed: 15310162
BMC Infect Dis. 2014 Oct 30;14:574
pubmed: 25358721
Epidemiol Infect. 2000 Jun;124(3):409-16
pubmed: 10982064
Med Mal Infect. 2005 Oct;35(10):492-9
pubmed: 16316731
Gut. 2012 Jan;61(1):69-77
pubmed: 21708822
Emerg Infect Dis. 2001 Jan-Feb;7(1):82-91
pubmed: 11266298
Epidemiol Infect. 2012 Apr;140(4):697-705
pubmed: 21676346
Epidemiol Infect. 2007 Feb;135(2):293-301
pubmed: 17291364
BMC Public Health. 2007 Jul 18;7:162
pubmed: 17640371
BMJ. 1997 Dec 20-27;315(7123):1645-9
pubmed: 9448526
Clin Microbiol Infect. 2014 Jan;20(1):17-21
pubmed: 24350723
BMJ. 1999 Apr 17;318(7190):1046-50
pubmed: 10205103
Gastroenterol Hepatol (N Y). 2008 Aug;4(8):572-8
pubmed: 21960939
Rev Med Suisse. 2009 Oct 7;5(220):1985-90
pubmed: 19908638
Commun Dis Public Health. 1999 Jun;2(2):101-7
pubmed: 10402743
Stat Methods Med Res. 2006 Oct;15(5):413-21
pubmed: 17089946
PLoS One. 2014 Dec 09;9(12):e114925
pubmed: 25490045

Auteurs

Marie Ecollan (M)

Sorbonne Université, INSERM, Institut Pierre Louis d'épidémiologie et de Santé Publique, IPLESP, F75012, Paris, France.
Department of Family Medicine, Faculté de Médecine, Université Paris Descartes, Paris, France.

Caroline Guerrisi (C)

Sorbonne Université, INSERM, Institut Pierre Louis d'épidémiologie et de Santé Publique, IPLESP, F75012, Paris, France.

Cécile Souty (C)

Sorbonne Université, INSERM, Institut Pierre Louis d'épidémiologie et de Santé Publique, IPLESP, F75012, Paris, France.

Louise Rossignol (L)

Sorbonne Université, INSERM, Institut Pierre Louis d'épidémiologie et de Santé Publique, IPLESP, F75012, Paris, France.
Département de Médecine Générale, Université Paris Diderot, Paris, France.

Clément Turbelin (C)

Sorbonne Université, INSERM, Institut Pierre Louis d'épidémiologie et de Santé Publique, IPLESP, F75012, Paris, France.

Thomas Hanslik (T)

Sorbonne Université, INSERM, Institut Pierre Louis d'épidémiologie et de Santé Publique, IPLESP, F75012, Paris, France.
Service de Médecine Interne, Hôpital Ambroise-Paré, Assistance Publique - Hôpitaux de Paris, APHP, 92100, Boulogne-Billancourt, France.
UFR des Sciences de la Santé Simone-Veil, Université de Versailles Saint-Quentin-en-Yvelines, 78280, Versailles, France.

Vittoria Colizza (V)

Sorbonne Université, INSERM, Institut Pierre Louis d'épidémiologie et de Santé Publique, IPLESP, F75012, Paris, France.

Thierry Blanchon (T)

Sorbonne Université, INSERM, Institut Pierre Louis d'épidémiologie et de Santé Publique, IPLESP, F75012, Paris, France. thierry.blanchon@upmc.fr.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH